UK's revised international travel rules approve AstraZeneca Covishield
London: After outrage over mandatory quarantine for Indians travelling to England, the United Kingdom government has approved formulations of the four listed vaccines, such as AstraZeneca Covishield, AstraZeneca Vaxzevria and Moderna Takeda.
In a reviewed travel guidelines released on Wednesday, the government announced new rules will apply from 4 am Monday 4 October.
One will be qualified as fully vaccinated if you are vaccinated either:
- under an approved vaccination programme in the UK, Europe, USA or UK vaccine programme overseas
- with a full course of the Oxford/AstraZeneca, Pfizer BioNTech, Moderna or Janssen vaccines from a relevant public health body in Australia, Antigua and Barbuda, Barbados, Bahrain, Brunei, Canada, Dominica, Israel, Japan, Kuwait, Malaysia, New Zealand, Qatar, Saudi Arabia, Singapore, South Korea, Taiwan or the United Arab Emirates (UAE)
Formulations of the 4 listed vaccines, such as AstraZeneca Covishield, AstraZeneca Vaxzevria and Moderna Takeda, qualify as approved vaccines.
You must have had a complete course of an approved vaccine at least 14 days before you arrive in England.
Where 2 doses of a vaccine are required for a full course, you will be able to:
- mix 2 different types of vaccine, for example, Oxford/AstraZeneca and Moderna
- have the 2 vaccinations under 2 different approved programmes, for example, Australia and Japan, UK and USA, EU and Canada
Until 4 October, mixed vaccines are only permitted if you are vaccinated under the UK, Europe, USA or UK overseas vaccination programme.